help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 3, 2008
Endocrinology, doi:10.1210/en.2007-0949
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/4/1898    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Janes, M. E.
Right arrow Articles by King, P. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janes, M. E.
Right arrow Articles by King, P. J.

Submitted on July 12, 2007
Accepted on December 26, 2007

Mechanisms of Adrenocorticotropin-Induced Activation of ERK1/2 MAP Kinase in the Human H295R Adrenal Cell Line

Mandy E. Janes, K. M. Emily Chu, Adrian J. L. Clark, and Peter J. King*

Centre for Endocrinology, Barts & the London, Queen Mary University of London, London EC1M 6BQ, UK

* To whom correspondence should be addressed. E-mail: p.j.king{at}qmul.ac.uk.

The role of ACTH in stimulating or inhibiting growth of adrenal cells has been a subject of some controversy. Reports that ACTH may stimulate ERK/MAP kinase in Y1 cells have suggested a role for cAMP in this process. In attempting to extend this work, the ACTH responses in the human H295R cell line have been studied. This cell line makes only a very modest cAMP response to ACTH, yet the ERK1/2 response is highly reproducible and immediate, but not prolonged. It is minimally reduced by the protein kinase A inhibitor, H89, but unaffected by PKC and calcium inhibitors. Inhibition of EGF receptor or other tyrosine kinase receptor transactivation was without effect, as was inhibition of c-Src activity or c-Src phosphorylation. The most effective inhibitor of this pathway was dansylcadaverine, an inhibitor of receptor internalization. These findings imply that ACTH-induced ERK1/2 activation in H295R cells is dependent on a mechanism distinct from that by which most G protein-coupled receptors activate ERK1/2, but which nevertheless seems to depend on receptor internalization.


Key words: Adrenocorticotropin • MAP kinase • adrenal cells • receptor internalization







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society